BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2268 related articles for article (PubMed ID: 20541662)

  • 1. DHEA, important source of sex steroids in men and even more in women.
    Labrie F
    Prog Brain Res; 2010; 182():97-148. PubMed ID: 20541662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. All sex steroids are made intracellularly in peripheral tissues by the mechanisms of intracrinology after menopause.
    Labrie F
    J Steroid Biochem Mol Biol; 2015 Jan; 145():133-8. PubMed ID: 24923731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DHEA and intracrinology at menopause, a positive choice for evolution of the human species.
    Labrie F; Labrie C
    Climacteric; 2013 Apr; 16(2):205-13. PubMed ID: 23126249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DHEA and its transformation into androgens and estrogens in peripheral target tissues: intracrinology.
    Labrie F; Luu-The V; Labrie C; Simard J
    Front Neuroendocrinol; 2001 Jul; 22(3):185-212. PubMed ID: 11456468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenal androgens and intracrinology.
    Labrie F
    Semin Reprod Med; 2004 Nov; 22(4):299-309. PubMed ID: 15635498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is dehydroepiandrosterone a hormone?
    Labrie F; Luu-The V; Bélanger A; Lin SX; Simard J; Pelletier G; Labrie C
    J Endocrinol; 2005 Nov; 187(2):169-96. PubMed ID: 16293766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic features of menopausal and postmenopausal applicants for life insurance.
    Schiefeling M
    J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The stress system in the human brain in depression and neurodegeneration.
    Swaab DF; Bao AM; Lucassen PJ
    Ageing Res Rev; 2005 May; 4(2):141-94. PubMed ID: 15996533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy.
    Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Berger L; Gilbert L; Martel C; Balser J
    Menopause; 2009; 16(5):907-22. PubMed ID: 19436225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma levels and secretion rate of steroids with anabolic activity in man.
    Vermeulen A
    Environ Qual Saf Suppl; 1976; (5):171-80. PubMed ID: 133798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
    Stephenson K; Neuenschwander PF; Kurdowska AK
    Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration.
    Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Bérubé R; Bélanger P; Berger L; Gilbert L; Martel C; Balser J
    Menopause; 2009; 16(5):897-906. PubMed ID: 19436226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenal and gonadal steroid hormone deficiency in the pathogenesis of rheumatoid arthritis.
    Wilder RL
    J Rheumatol Suppl; 1996 Mar; 44():10-2. PubMed ID: 8833045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
    Brinton RD
    Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Science of intracrinology in postmenopausal women.
    Labrie F; Bélanger A; Pelletier G; Martel C; Archer DF; Utian WH
    Menopause; 2017 Jun; 24(6):702-712. PubMed ID: 28098598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extragonadal synthesis of sex steroids: intracrinology.
    Labrie F
    Ann Endocrinol (Paris); 2003 Apr; 64(2):95-107. PubMed ID: 12773942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone.
    Labrie F; Luu-The V; Labrie C; Bélanger A; Simard J; Lin SX; Pelletier G
    Endocr Rev; 2003 Apr; 24(2):152-82. PubMed ID: 12700178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 114.